首页> 外文期刊>The Journal of Veterinary Medical Science >Immune Recovery Effects of Immunopotentiator from Pantoea agglomerans 1 (IP-PA1) on Low Antibody Productions in Response to Salmonella Enteritidis Vaccine and Sheep Red Blood Cells in Dexamethasone-Treated Stressed Chicken Models
【24h】

Immune Recovery Effects of Immunopotentiator from Pantoea agglomerans 1 (IP-PA1) on Low Antibody Productions in Response to Salmonella Enteritidis Vaccine and Sheep Red Blood Cells in Dexamethasone-Treated Stressed Chicken Models

机译:在地塞米松处理的应激鸡模型中,结团泛菌1(IP-PA1)免疫增强剂对肠炎沙门氏菌疫苗和绵羊红细胞应答低抗体生产的影响

获取原文
       

摘要

References(37) Cited-By(4) Considering the usefulness of the immunopotentiator from Pantoea agglomerans 1 (IP-PA1), which is a purified lipopolysaccharide (LPS) derived from symbiotic gram-negative bacteria of food crops, in controlling immunosuppression in poultry husbandry, in this study, we examined its immune-recovery effects in dexamethasone-treated stressed chicken models. Three-week-old chickens daily administered 10 μg/kg of dexamethasone for 35 days to induce stress showed more whole body weight loss; relative thymic, bursal, and splenic weight losses; and decrease in the number of peripheral blood lymphocytes, as compared with the control chickens on day 35; the IP-PA1-pretreated, dexamethasone-treated chickens showed reduced weight losses. Five- to eight-week-old chickens administered 5 mg/kg of dexamethasone showed excessive apoptosis of thymic and bursal lymphocytes 24 hr after a single dexamethasone treatment; apoptosis was inhibited in the IP-PA1-pretreated, dexamethasone-treated chickens. Chickens daily administered 10 μg/kg of dexamethasone for 35 days and injected with commercial Salmonella Enteritidis (SE) vaccine or sheep red blood cells (SRBC) on days 7 and 21 showed about 8- or 2-fold lower antibody production in response to SE or SRBC, respectively, as compared with the control chickens on day 35; the antibody production in response to SE or SRBC was increased in the IP-PA1-pretreated, dexamethasone-treated chickens. These results indicate that IP-PA1 exerts inhibitory effects on dexamethasone-induced immunosuppression and that it may be useful in controlling immunosuppression in poultry husbandry.
机译:参考文献(37)(4)考虑到来自泛菌团1(IP-PA1)的免疫增强剂在控制禽类免疫抑制方面的作用,该增强剂是一种由食用农作物的共生革兰氏阴性细菌衍生的纯化脂多糖(LPS)。饲养,在这项研究中,我们检查了地塞米松治疗的压力鸡模型的免疫恢复作用。三周大的鸡每天服用10μg/ kg地塞米松35天以诱导压力,表明整个人体重减轻了更多。胸腺,法氏囊和脾脏相对体重减轻;与第35天的对照组鸡相比,外周血淋巴细胞数量减少;经IP-PA1预处理,地塞米松处理的鸡体重减轻。给予地塞米松5 mg / kg的5至8周大的鸡在一次地塞米松治疗后24小时显示胸腺和法氏囊淋巴细胞过度凋亡; IP-PA1预处理地塞米松处理的鸡的细胞凋亡受到抑制。每天给鸡注射10μg/ kg地塞米松35天,并在第7天和第21天注射商业性肠炎沙门氏菌(SE)疫苗或绵羊红细胞(SRBC),对SE产生的抗体降低约8或2倍与第35天的对照鸡相比,分别为SRBC或SRBC;经IP-PA1预处理,地塞米松处理的鸡对SE或SRBC的抗体产生增加。这些结果表明,IP-PA1对地塞米松诱导的免疫抑制具有抑制作用,并且在控制家禽饲养业的免疫抑制中可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号